Edition:
United States

Trans Genic Inc (2342.T)

2342.T on Tokyo Stock Exchange

613JPY
26 May 2017
Change (% chg)

¥-2 (-0.33%)
Prev Close
¥615
Open
¥618
Day's High
¥621
Day's Low
¥611
Volume
64,000
Avg. Vol
82,727
52-wk High
¥736
52-wk Low
¥522

Latest Key Developments (Source: Significant Developments)

Trans Genic to sell entire 30 pct stake in Kobe medicine firm for 3 mln yen
Friday, 22 Jul 2016 02:43am EDT 

Trans Genic Inc <2342.T>: Says it will sell entire 30 percent stake in a Kobe-based medicine company to an individual on Sep. 30 .Says transaction price is 3 million yen.  Full Article

Trans Genic says cellular stress-visualized mouse has been patents in Japan
Monday, 11 Jul 2016 02:33am EDT 

Trans Genic Inc <2342.T>:Says cellular stress-visualized mouse has been patented in Japan.  Full Article

TRANS GENIC receives patent in Europe
Wednesday, 27 Apr 2016 03:00am EDT 

TRANS GENIC INC:Says patent regarding oxidative stress visualization mice has been granted in Europe.  Full Article

CURED to issue shares to TRANS GENIC
Wednesday, 20 Apr 2016 03:00am EDT 

TRANS GENIC INC:Says Japan-based co CURED to issue 21,000 shares to TRANS GENIC via private placement for 79,800,000 yen in total on May 11.Says it to hold 7.6 pct stake in CURED up from 0 pct after transaction.  Full Article

TRANS GENIC amends consolidated full-year outlook for FY 2016
Wednesday, 20 Apr 2016 03:00am EDT 

TRANS GENIC INC:Says the company amended the consolidated full-year outlook for the FY ended March 2016.Revenue forecast revised to 2,290 million yen from 2,150 million yen.Operating profit forecast revised to 50 million yen from 40 million yen.Ordinary profit forecast revised to 18 million yen from 35 million yen.Net profit forecast revised to 14 million yen from 18 million yen.Earnings per share revised to 1.05 yen from 1.29 yen.Comments that successfully business and impact of expense are the main reasons for the forecast.  Full Article

TRANS GENIC to acquire shares of Medicinal Chemistry Pharmaceuticals
Thursday, 24 Mar 2016 02:30am EDT 

TRANS GENIC INC:Says Medicinal Chemistry Pharmaceuticals Co.,Ltd. to issue 1,250 shares to the company for 50 mln yen, via private placement.Says the company to hold 35.6 pct stake (3,750 shares) in Medicinal Chemistry Pharmaceuticals, up from 31.7 pct (2,500 shares).Planned effective March 31.  Full Article

TRANS GENIC signs exclusive distribution agreement with Deltagen
Wednesday, 9 Mar 2016 06:45pm EST 

TRANS GENIC INC:Signs an agreement with Deltagen, Inc. on March 10 to grant TRANS GENIC the exclusive distribution rights on the worldwide use of the knockout mouse owned by Deltagen.  Full Article

TRANS GENIC to acquire shares of Immuno-Biological Laboratories
Friday, 12 Feb 2016 03:30am EST 

TRANS GENIC INC:To acquire 205,000 shares of Immuno-Biological Laboratories for 200,000,000 yen on March 1.To hold 3.04 pct stake in Immuno-Biological Laboratories up from 0 pct.  Full Article

TRANS GENIC issues new shares and issues 3rd series convertible corporate bonds with warrants
Thursday, 17 Dec 2015 01:30am EST 

TRANS GENIC INC:Issued 103,000 new shares of its common stock through private placement at price of 777 yen per share, for 80,031,000 yen in total, with payment date on Dec. 17.Issued 3rd series convertible corporate bonds with warrants and raised 200 mln yen in total, with payment date on Dec. 17 and maturity date Dec. 16, 2017.  Full Article

TRANS GENIC to issue new shares; to issue 3rd series convertible corporate bonds with warrants
Tuesday, 1 Dec 2015 04:30am EST 

TRANS GENIC INC:To issue 103,000 new shares of its common stock through private placement at price of 777 yen per share, for 80,031,000 yen in total, with payment date on Dec. 17.To issue 3rd series convertible corporate bonds with warrants worth 200 mln yen, with payment date on Dec. 17.The bonds are each with face value of 100 mln yen, issue price at 100 yen per face value of 100 yen and coupon rate 1 pct per annum.  Full Article

More From Around the Web